Neuropathic pain and pharmacological management in particular
January 2015
(What is Pain Review Monthly? click here to find out.)
(Click here to go to IASP and read the definition yourself)
For more detailed description of each the roles click here.
References
Dworkin RH et al, Pharmacologic management of neuropathic pain, Evidence-based recommendations. Pain. 2007;132: 237-251.
Woolf CJ. Pain: Moving from symptom control toward mechanism-specific pharmacologic management. Annals of Internal Medicine. 2004;140:441-451
Smith BH el at, Neuropathic pain: a pathway for care developed by the British Pain Society. British Journal of Anaesthesia. 2013; 111(1):73-9
Vargas-Schaffer G, Is the WHO analgesia ladder still valid?. Canadian Family Physician 2010; 56:514-7-0 5.
Okubo M et al, Transition to persistent orofacial pain after nerve injury involves supraspinal serotonin mechanisms. The Journal of Neuroscience, 2013;33(12):5152-5161
Jensen TS et al, A new definition of neuropathic pain. Pain. 2011;152:2204-2205
Dworkin RH et al, Advances in neuropathic pain. Archives of Neurology. 2003;60:1523-1534
Jensen IB et al, 3-year follow up of a multidisciplinary rehabilitation programme for back and neck pain. Pain. 2005;115:273-283
Neuropathic pain (2014 Dec 30th). Retreived from http://www.iasp-pain.org/Taxonomy?navItemNumber=576#Neuropathicpain
http://www.2will.co.nz/january-2015/
No comments:
Post a Comment
All comments welcome but advertising your own service or product will unfortunately result in your comment not being published.